Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
Vistagen Therapeutics, Inc. Reports FY 2026 Financial Results
2026-06-15
SEC Filing 10-K
(0001628280-26-043271)
Please check the link below for details.
Ticker mentioned:
VTGN
Source:
Original SEC Document β